Hericium erinaceus is the subject of promising research regarding its role in cardiovascular protection, particularly through its action on coagulation. This page explores studies demonstrating the ability of some of its unique compounds, hericenones, to inhibit platelet aggregation in a targeted manner. By limiting collagen-induced clot formation, Hericium acts as a natural support for blood fluidity and the prevention of circulatory disorders.

⚠️ SAFETY WARNING: Due to its anticoagulant properties, the consumption of Hericium erinaceus is not recommended for individuals on anticoagulant or antiplatelet medication, nor for those scheduled for surgery (discontinuation is recommended 2 weeks prior to the procedure). Always seek medical advice.

Inhibitory effect of hericenone B from Hericium erinaceus on collagen-induced platelet aggregation
Phytomedicine
– Koichiro Mori & Al.
Experiment: in vitro (rabbit blood)
Download the original paper

Summary: This in vitro study demonstrated the inhibitory effect of hericenone B, extracted from Hericium erinaceus, on platelet aggregation. Researchers observed that this compound specifically blocks platelet clumping induced by collagen, a key process in blood clot formation (thrombosis). Unlike other agents, hericenone B acts on a highly targeted biological pathway, suggesting potential protection against cardiovascular events and strokes. This discovery positions Hericium as a natural support for blood fluidity, while highlighting the importance of caution when used alongside anticoagulant treatments.